Strain identifier

BacDive ID: 2582

Type strain: Yes

Species: Clostridioides difficile

Strain Designation: 1780, McClung 1780

Culture col. no.: DSM 1296, ATCC 9689, NCIB 10666, NCTC 11209, CCUG 4938, USDA 90556-M6S, JCM 1296, BCRC 10642, CECT 531, CIP 104282, LMG 15861, LMG 21717, NCIMB 10666

Strain history: ATCC 9689 <-- F. E. Clark 90556-M6S (L. S. McClung 1780).

NCBI tax ID(s): 1496 (species)

« Browse strain by BacDive ID »

expand / minimize allblue arrow down

Exclude non-curated data/information

Clostridioides difficile 1780 is an anaerobe, spore-forming, mesophilic human pathogen that produces toxins and was isolated from Human feces.

  1. toxin production
  2. rod-shaped
  3. spore-forming
  4. anaerobe
  5. human pathogen
  6. mesophilic
  7. 16S sequence
  8. Bacteria
  9. genome sequence
  • Availability in culture collections External linksarrow_down
  • [Ref.: #627] Culture collection no. DSM 1296, ATCC 9689, NCIB 10666, NCTC 11209, CCUG 4938, USDA 90556-M6S, JCM 1296, BCRC 10642, CECT 531, CIP 104282, LMG 15861, LMG 21717, NCIMB 10666
    [Ref.: #20218] Associated Passport(s) in StrainInfo 54562, 54558, 149954, 54566
    Literature: Only first 10 entries are displayed. Click here to see all.Click here to see only first 10 entries.
    Topicarrow to sort Titlearrow to sort Authorsarrow to sort Journalarrow to sort DOIarrow to sort Yeararrow to sort
    Enzymology Purification and characterization of Clostridium difficile toxin. Rolfe RD, Finegold SM Infect Immun 10.1128/iai.25.1.191-201.1979 1979 *
    Pathogenicity In vitro and in vivo evaluation of tiacumicins B and C against Clostridium difficile. Swanson RN, Hardy DJ, Shipkowitz NL, Hanson CW, Ramer NC, Fernandes PB, Clement JJ Antimicrob Agents Chemother 10.1128/AAC.35.6.1108 1991 *
    Pathogenicity Fusidic acid disk diffusion testing of clostridium difficile can be calibrated using single-strain regression analysis. Oppenheimer M, Kronvall G, Karlsson I, Holst E Scand J Infect Dis 10.1080/003655400459540 2000 *
    Pathogenicity Adhesion of selected Bifidobacterium strains to human intestinal mucus and the role of adhesion in enteropathogen exclusion. Collado MC, Gueimonde M, Hernandez M, Sanz Y, Salminen S J Food Prot 10.4315/0362-028x-68.12.2672 2005 *
    Pathogenicity Inhibition of Clostridium difficile growth and adhesion to enterocytes by Bifidobacterium supernatants. Trejo FM, Minnaard J, Perez PF, De Antoni GL Anaerobe 10.1016/j.anaerobe.2006.03.004 2006 *
    Biotechnology Exopolysaccharides produced by probiotic strains modify the adhesion of probiotics and enteropathogens to human intestinal mucus. Ruas-Madiedo P, Gueimonde M, Margolles A, de los Reyes-Gavilan CG, Salminen S J Food Prot 10.4315/0362-028x-69.8.2011 2006 *
    Pathogenicity Experimental evaluation of an automated endoscope reprocessor with in situ generation of peracetic acid for disinfection of semicritical devices. Sattar SA, Kibbee RJ, Tetro JA, Rook TA Infect Control Hosp Epidemiol 10.1086/508830 2006 *
    Metabolism Identification of a novel virulence factor in Clostridium difficile that modulates toxin sensitivity of cultured epithelial cells. Miura M, Kato H, Matsushita O Infect Immun 10.1128/IAI.00051-11 2011 *
    Pathogenicity Sensitivity of pathogenic and commensal bacteria from the human colon to essential oils. Thapa D, Losa R, Zweifel B, Wallace RJ Microbiology (Reading) 10.1099/mic.0.061127-0 2012 *
    Pathogenicity Using phenotype microarrays to determine culture conditions that induce or repress toxin production by Clostridium difficile and other microorganisms. Lei XH, Bochner BR PLoS One 10.1371/journal.pone.0056545 2013 *

Change proposal

You found an error in BacDive? Please tell us about it!

Note that changes will be reviewed and judged. If your changes are legitimate, changes will occur within the next BacDive update. Only proposed changes supported by the according reference will be reviewed. The BacDive team reserves the right to reject proposed changes.

Field you want to change:

CAPTCHAReload captcha

Change proposal

Successfully sent